191 related articles for article (PubMed ID: 35805039)
1. Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis.
Ito A; Akama Y; Satoh-Takayama N; Saito K; Kato T; Kawamoto E; Gaowa A; Park EJ; Takao M; Shimaoka M
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805039
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
3. Obesity correlates with the immunosuppressive ILC2s-MDSCs axis in advanced breast cancer.
Liu W; Li B; Liu D; Zhao B; Sun G; Ding J
Immun Inflamm Dis; 2024 Mar; 12(3):e1196. PubMed ID: 38501542
[TBL] [Abstract][Full Text] [Related]
4. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
5. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
[TBL] [Abstract][Full Text] [Related]
6. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
[TBL] [Abstract][Full Text] [Related]
7. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
8. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
Trabanelli S; Chevalier MF; Martinez-Usatorre A; Gomez-Cadena A; Salomé B; Lecciso M; Salvestrini V; Verdeil G; Racle J; Papayannidis C; Morita H; Pizzitola I; Grandclément C; Bohner P; Bruni E; Girotra M; Pallavi R; Falvo P; Leibundgut EO; Baerlocher GM; Carlo-Stella C; Taurino D; Santoro A; Spinelli O; Rambaldi A; Giarin E; Basso G; Tresoldi C; Ciceri F; Gfeller D; Akdis CA; Mazzarella L; Minucci S; Pelicci PG; Marcenaro E; McKenzie ANJ; Vanhecke D; Coukos G; Mavilio D; Curti A; Derré L; Jandus C
Nat Commun; 2017 Sep; 8(1):593. PubMed ID: 28928446
[TBL] [Abstract][Full Text] [Related]
10. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
11. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
12. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for
Jou E; Rodriguez-Rodriguez N; Ferreira AF; Jolin HE; Clark PA; Sawmynaden K; Ko M; Murphy JE; Mannion J; Ward C; Matthews DJ; Buczacki SJA; McKenzie ANJ
Sci Immunol; 2022 Jun; 7(72):eabn0175. PubMed ID: 35658010
[TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells.
Cao Y; He Y; Wang X; Liu Y; Shi K; Zheng Z; Su X; Lei A; He J; Zhou J
Immunology; 2019 Apr; 156(4):402-412. PubMed ID: 30575026
[TBL] [Abstract][Full Text] [Related]
14. SOCS3 Suppression Promoted the Recruitment of CD11b
Zhang W; Jiang M; Chen J; Zhang R; Ye Y; Liu P; Yu W; Yu J
Front Immunol; 2018; 9():1699. PubMed ID: 30083161
[TBL] [Abstract][Full Text] [Related]
15. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.
Su MT; Kumata S; Endo S; Okada Y; Takai T
Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083
[TBL] [Abstract][Full Text] [Related]
16. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
Bayik D; Lee J; Lathia JD
Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
[TBL] [Abstract][Full Text] [Related]
17. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.
Xiao P; Wan X; Cui B; Liu Y; Qiu C; Rong J; Zheng M; Song Y; Chen L; He J; Tan Q; Wang X; Shao X; Liu Y; Cao X; Wang Q
Oncoimmunology; 2016; 5(1):e1063772. PubMed ID: 26942079
[TBL] [Abstract][Full Text] [Related]
19. Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung.
Zhang Z; Yao Z; Zhang Z; Cui L; Zhang L; Qiu G; Song X; Song S
Cancer Cell Int; 2023 Jun; 23(1):107. PubMed ID: 37268941
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer.
Ma X; Wang M; Yin T; Zhao Y; Wei X
Front Oncol; 2019; 9():855. PubMed ID: 31552179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
